Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Conference Correspondent
ASCO 2015
ASCO 2015 Highlights
Who Should Attend Meetings
By
Michael Kolodziej, MD
Videos
Michael Kolodziej, MD, talks about who would benefit in attending such conferences, and some of the takeaways from such meetings.
Read Article
Emerging Trends
By
Gary Palmer, MD
Videos
Gary Palmer, MD, JD, MBA, MPH talks about the challenges related to costs facing community oncologists and some of the consequences of it.
Read Article
Cost and Quality
By
Michael Kolodziej, MD
Videos
Michael Kolodziej, MD, talks about how oncologists' perspectives have changed to understand that cost and quality do not have to be at odds with one another.
Read Article
Surveying the Cancer Care Landscape
By
Gary Palmer, MD
Videos
Gary Palmer, MD, JD, MBA, MPH points out the value for oncologists, industry, and the payers to know where oncology is going in order to stay current of the trends and its future.
Read Article
Value Propositions - October 2016
Value Propositions
,
Value Peer-spectives
October 2016, Vol 7, No 9
Read Article
ASCO Names the 14 Oncology Practices Participating in the 2016 Quality Training Program, Highlighting Significant Improvements in Care Delivery
By
Laura Morgan
Oncology Practice
October 2016, Vol 7, No 9
Read Article
Biology, Genetics Guide Diagnosis and Treatment of Thyroid Cancers
By
Charles Bankhead
Personalized Medicine
,
Thyroid Cancer
October 2016, Vol 7, No 9
Recent advances in the management of thyroid cancer have evolved directly from improved knowledge of the underlying genetics and molecular biology, an understanding that will continue to improve in the future, according to a recent review.
Read Article
Is Direct-to-Consumer Advertising for Cancer Drugs Beneficial to Patients?
By
Jessica Miller
Health Policy
,
Policies & Guidelines
October 2016, Vol 7, No 9
Read Article
DCIS Score Not Cost-Effective in Selecting Patients for Adjuvant Radiation
By
Wayne Kuznar
Value in Oncology
October 2016, Vol 7, No 9
Read Article
Hematologic Cancers Among the Most Costly Malignancies to Treat
By
Alice Goodman
Hematologic Cancers
,
Value in Oncology
October 2016, Vol 7, No 9
Read Article
Page 147 of 330
144
145
146
147
148
149
150
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Gaps in Biomarker Testing and Targeted Therapy for Gastric Cancer
Ashley Gamble, PhD
,
John Perez, MBA, MSDS
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma